We are the first company to commercialize human Trophoblastic Stem Cells (TSC) from embryonic-stage pre-placental tissue. By working with us, you build off our position as first-to-market proprietary cell source.
Accelerated Biosciences lets you put capital to work in the right places by leveraging our expertise and efficiency in producing TSCs.
Our TSCs come from ectopic pregnancies 4-8 weeks post-fertilization.
Earlier sourced cells are naive, powerful, and lively. They have a high plasticity making them an ideal source for therapy development.
One cell source for all therapies.
Stable source of TSC secretome:
cytokines, growth factors, & exosomes
Our TSC product is purified human Trophoblast Stem Cells, isolated from embryonic-stage ectopic pregnancies which account for 2% of all pregnancies.
TSC is isolated from the pre-placental trophectoderm, avoiding ethical issues and funding issues often associated with human embryonic stem cells.
Our cells show robust growth in suspension using bioreactors for 50M Cells for proof of concept.
With viability above 95% and 44X growth you can be assured that your manufacturing scale up will be successful.
Accelerated Biosciences can save your company time and money by shaving 3-5 years off development timelines and saving up to $10M.
Start a conversation
Presenting
Presenting
Poster
Presenting
Attending
Attending
Attending
